MAD GLOBAL STRATEGY

Lobbying for ADNEURIS THERAPEUTICS, INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · Senate · $15,000.00 income · posted Jul 1, 2026

Lobbying activity 1

Pharmacy

Education on new drug seeking FDA approval

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem